Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$153.50
-0.95-0.62%
Last update: Oct 21, 12:11 PM
$147.30
-7.15-4.63%
Belite Bio Inc (BLTE) Stock Price, Quote, News & History
BLTENASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.
Other companies in Belite Bio’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Belite Bio has a consensus price target of $197.22.
The stock price for Belite Bio (NASDAQ: BLTE) is $153.5 last updated October 21, 2026 at 12:11 PM EDT.
There are no upcoming dividends for Belite Bio.
Belite Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Belite Bio.
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
